chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Intense pain from face to feet on left side; Fever; Chills; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 320308D) in the left arm on 04Nov2021 at 11:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination which included influenza vaccine (flu) (MANUFACTURER UNKNOWN) on 20Oct2021 for immunization. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and doxepin (MANUFACTURER UNKNOWN), both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received thiomersal (THIMEROSAL) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246) in the left arm on 08Feb2021 (at the age of 71-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) in the left arm on 01Mar2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. On 04Nov2021 at 12:00, the patient experienced intense pain from face to feet on left side, fever and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense pain from face to feet on left side, fever and chills were resolving at the time of this report.
Within a few hrs of immunization on 9/30, pt's arm began to itch. Became swollen and red. Next day-sought treatment. MD Rx'd hydroxyzine HCL. Also SMX/TMP on 10/2.
The patient experienced numbness on part of her tongue after the immunization was given. The patient reported approximately ten minutes after administration that she was experiencing this. I gave her one 50 mg Diphenhydramine. I remained there for a 1.5 after the injection was given. I spoke with the patient before I left and she stated that she was fine but her tongue still "felt funny."
A red area radiated down from the injection site which was at least six inches long and 4 inches wide.
Patient appears to be sleepy and lethargic after 15 minutes post vaccines. Patient responsive to command and alert but sleepy.
Information has been received from a physician concerning a patient who was vaccinated with a does of varicella virus vaccine live. Subsequently, on approximately 09/18/2000, the patient developed a breakthrough rash. It was reported that the grandmother, who is the baby-sitter, was on chemotherapy. Additional information has been requested.
Noticed 1" swollen area about 24 hrs after injection, treated with Benadryl area grew to 4" over next 24 hrs. Took to emergency room, 7-4-07, started on Cephalexen 7-4-07 some puffiness subsided.
RECEIVED TOO EARLY 1ST DOSE 9/2, 2ND DOSE 9/16
pt developed welts at the injection site on theright deltoid and a stiff right neck about 6 days after the injection.He then developed pain at the shoulder and pustules at the rash. A few days later bumps behind right ear appeared as well as bumps on right arm.
A pediatric infectious disease physician reported that a 12 month old male child received a 3rd dose of Prevnar, 2nd dose of HibTiter, 2nd dose of Infanrix, 2nd dose of Polio vaccine, and Varivax vaccines on 1/11/02. Medical history includes cough and fever. The onset date of pneumococcal illness was reported as 3/12/02, when the pt was 14 months old. On 3/18/02, the child presented to the health care providers office in respiratory distress. On 3/18/02, the child was hospitalized and diagnosed with bacteremia due to streptococcus pneumoniae from pneumonia and empyema. A "chest x-ray was C/W (consistent with) fluid, and pneumonia." A blood culture and pleural fluid culture were positive for streptocuccus pneumoniae, serotype 19A (not a Prevnar serotype) and a white blood cell count was 30,000. The child underwent a thorascopic decortication and was treated with antibiotics. On 3/28/02, the pt was discharged from the hospital to home. He recovered and "did well." These events were considered life-threatening and required medical intervention. No additional info was available as of the date of this report.   A 15-day followup report dated 01/23/2003 adds:  PNEUMOCOCCAL SEPSIS (LLT PNEUMOCOCCAL SEPSIS): Pneumonia pneumococcal (LLT Pneumonia Pneumococcal); Empyema NOS (LLT Empyema NOS): Drug ineffective (LLT Drug ineffective)  PNEUMOCOCCAL SEPSIS. Follow-up information received 1/10/2003 contained test results and other medical records from hospitalization.
About a month after the vaccine I developed SOB and noticed my BP started being elevated resulting in me reaching out to my PCP. Bloodwork was performed and I was diagnosed with Asthma. During that visit my BP was 190/125 but I have never experienced Hypertension in no form in the past. An X-ray was performed and a nodule was noticed on my lung so I was referred to have a CT scan. The CT scan showed the nodule was benign but its still there and still to date I am still experiencing the SOB but it has gotten better but I have been since put on an inhaler to help with the SOB.
she could not feel her body from the neck down- She believes the vaccine paralyzed most of her body.; she could not feel her body from the neck down- She believes the vaccine paralyzed most of her body.; This is a spontaneous report from a contactable consumer. A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number-UNKNOWN) via an unspecified route of administration on unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced she could not feel her body from the neck down- she believes the vaccine paralyzed most of her body on an unspecified date. The patient underwent lab tests and procedures which included blood test: clear and/or negative, lumbar puncture: clear and/or negative, magnetic resonance imaging: clear and/or negative. The outcome of events was unknown.   Follow-up (19Apr2021): This follow-up contains no new safety information.  Follow-up attempts have been completed and no further information is expected.
This spontaneous report was received from a Physician Assistant, referring to an unspecified number of patients of unknown age and gender. Their historical condition, concurrent condition, concomitant therapy, historical drugs or allergies were not reported. On unknown dates, the patients may had received an improperly stored doses of PEDVAXHIB injection, intramuscular route, with lot number N024571, expiration date 01-MAY-2020 (strength, dose and frequency were not reported) for prophylaxis. No adverse effects were reported. The administered dose of the vaccine experienced a temperature excursion 9 degrees to 25 degrees Celsius for 12 hours 28 minutes, as recorded by a data logger. No product quality complaint was filed.
Information has been received from a claims management agency representing a pharmacy concerning a female patient, with an unknown medical history, who on an unspecified date, received a dose of PNEUMOVAX23. Subsequently on 02-OCT-2012 the patient experienced an adverse reaction after receiving the vaccine. No additional information has been provided. Additional information has been requested.
Pruritic rash on trunk, extremities within days of receiving vaccine.   Appears as Pityriasis Rosea.   After 2nd dose, worsened significantly.
Expired Moderna was administered on 11/19/2021 lot# 046C21A. Offender was called back to the clinic and vital signs were taken and were within normal limits. Offender showed no s/s of any distress and when asked he states no s/s. Provider was notified and also Moderna manufacture and they will update with guidelines. Offender was release back to security.
this is 1 of 6 pt from this site to indavertently recv intracutaneous inj of Td rather than PPD;pt devel an inj site rxn characterized by swelling, redness, pain, itching, warmth;
Very sore at site of injection; extreame fatigue; a little headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very sore at site of injection), FATIGUE (extreame fatigue) and HEADACHE (a little headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0 21B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Psoriatic arthritis (Psoratiac Arthritis) since 01-Jan-1999. Concomitant products included PREDNISONE from 01-Jan-1999 to an unknown date and OXYCODONE from 01-Jan-1999 to an unknown date for Psoriatic arthritis.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Sep-2021, the patient experienced PAIN IN EXTREMITY (Very sore at site of injection), FATIGUE (extreame fatigue) and HEADACHE (a little headache). The patient was treated with IXEKIZUMAB (TALTZ) from 04-Jul-2021 to 07-Jul-2021 for Psoriatic arthritis, at a dose of 1 dosage form. On 13-Sep-2021, PAIN IN EXTREMITY (Very sore at site of injection) and FATIGUE (extreame fatigue) had resolved. On 14-Sep-2021, HEADACHE (a little headache) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: The follow-up document received contain ne Information (medical history, concomitant meds) On 17-Sep-2021: Follow- up document received contain significant information - New events added and dosage information updated.
Mom called the clinic 48 hours later the pt experienced spots around the site of injection and on legs. Called 72 hours later and more spots appearing. No fever, no difficulty breathing. The pt then developed hives which appeared on trunk, under arms and both legs. No other problems noted.
A little headache; Achy arm; little tired; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number, NDC number and Expiry Date are not provided), via an unspecified route of administration on 29Mar2021 as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history included first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on 08Mar2021 for covid-19 immunisation. The patient previously took lamisil [terbinafine hydrochloride] and experienced horrible reaction she had with Lamisil a few years ago on an unspecified date. While calling to report on her husband, caller reported that she experienced what she stated to be the normal, classic reaction. Caller reported that after taking Lamisil, she lost her sense of taste for 6 months. Caller reported that after losing her sense of taste, she had to put hot sauce on everything just to be able to taste anything. Caller reported that she followed up with her physician and that her physician looked through all of the side effects of Lamisil. Caller stated that she understands that there has to be a certain percentage of patients that experience side effects before the side effects are listed on the prescribing information. Caller reported that losing the sense of taste after taking Lamisil was a reaction, but it had not occurred enough to put on the prescribing information and that the experience of her husband was kind of a bingo thing. Caller reported that she was one of the fortunate people that had no taste after taking Lamisil. Caller reported that she survived that, but she can no longer take Lamisil. The patients concomitant medications were not reported. It was reported that, she had her first dose of the Pfizer Covid-19 vaccine on 08Mar2021 and the second dose on 29Mar2021. Caller reported earlier in the call that she had experienced a little bit of a headache, an achy arm, and was a little tired on an unspecified date in Mar2021 after receiving the Covid-19 vaccine. Investigation assessment was not provided. The reporter assessed events as non-serious. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected
Information has been received from a medical assistant concerning a 9 week old female baby with milk protein allergy who on 05-APR-2010 and 07-JUN-2010 was vaccinated with the first (lot # not reported) and the second dose (lot # 664067/0318Y, expiration date 12-DEC-2010) of ROTATEQ, respectively. Concomitant therapy included PENTACEL and PREVNAR. At the baby's six month visit, her mother told the office that for the 24-36 hours following both the first and second doses of ROTATEQ (on approximately 05-APR-2010 and 07-JUN-2010, respectively), the baby had blood in her stool. No other signs or symptoms were reported. No testing was done. No treatment was needed, and the baby was fine. The third dose of ROTATEQ was to be given. Subsequently (in 2010), the patient recovered from blood in her stool. Upon internal review, the two episodes of blood in stool were considered to be other important medical events. No further information is available.
2 small blisters near the site of injection about 2 weeks after the injection. They were initially itchy but scabbed & dried. A few days later a small lesion on her chin and upper right arm which are resolving.
This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (EL8982) via an unspecified route of administration on 21Jan2021 12:30 at single dose in left arm for COVID-19 immunisation. No additional vaccines administered on same date of Pfizer suspect. Medical history included COVID-19 virus from Jun2020 to an unknown date. There were no concomitant medications. The patient reported fever, joint pain and tiredness, experienced fever, cold and chills after the first dose, all on Jan2021. She was asking how long these symptoms usually persist. The patient received COVID shot last Thursday. Had chills, fever, ugly fever blisters, and fatigue. The patient asked how long does the fatigue stay in the system because she is really tired. She was tired since 22Jan2021. She had chills on the night of 22Jan2021. She is done with fever and chills, she is just tired. Had COVID-19 virus in Jun2020. Feel like she has it again. The temperature was 99 degrees, began on night of 22Jan2021. Fever blisters started on 23Jan2021 reported as are subsiding, but still present. She was still really tired. Woke up Saturday and thought she had COVID-19 virus all over again. The events did not require visit to AES, because she was ok. Event outcome of fever blisters was not recovered, while for others was unknown.
I went to four concerts over the Friday, Saturday, and Sunday of weekend. Drove back and started to feel sick November 1st. There?s an active online group surrounding the band I?d seen and others have been posting about being sick since the shows as well. Very few are testing positive for Covid and most are experiencing what I am. Basically, it?s been sore throat, pressure in chest early on, a cough, lack of appetite and some stomach discomfort after eating, slight headache, sinus drip. I looked at my throat the Friday night after I started feeling sick and noticed redness and that it just didn?t look right. Couldn?t get to a minute clinic appointment until Sunday. They tested for strep, Covid, and flu; all were negative. She diagnosed me with an acute upper respiratory infection. I?ve started feeling better in the last couple days, but still have symptoms.
I received my third dose of Pfizer Covid vaccine on 19Aug2021; I received my third dose of Pfizer Covid vaccine on 19Aug2021; just to the side of injection site on my arm it's kind of swollen like a two inch swollen area and it was red and sore; has a little swelling; just to the side of injection site on my arm it's kind of swollen like a two inch swollen area and it was red and sore; has a little swelling; just to the side of injection site on my arm it's kind of swollen like a two inch swollen area and it was red and sore; has a little swelling; This spontaneous report from contactable consumer (patient).   A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration, on 19Aug2021, as a dose 3, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Batch/Lot number: not reported), via an unspecified route of administration, on unspecified date at, as a dose 1, single and dose 2, single for COVID-19 immunization. It was reported that patients first two doses were uneventful. On unspecified date patient experienced injection site on patient arm it was kind of swollen like a two inch swollen area and it was red and sore and now it's not sore but it was still had a little swelling. Patient was wondering how many days patient can expect that to last. Outcome of events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Resident of a facility  received second booster 6 days early at an on-site vaccine clinic.
Patient moved away during administration. Less than half dose delivered. Readministered full dose at site.
Acute pulmonary embolism with acute cor pulmonale, Acute respiratory failure with hypoxia,
Adverse event:  Itchy rash at waistline, shoulder (not side of injection), and between thighs consisting of small hard bumps over a widespread area.  New bumps continue to appear on chest and arm but only one or two so far. The bumps sting when they appear and then turn itchy.  Time: April 30, 2021 to present (May 10, 2021) -- new bumps still appearing.
friend became sick; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non-HCP).  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown" described as "friend became sick."  Additional information: Another person mentioned that a friend became sick after taking an unknown COVID vaccine.   The information on the batch/lot number for COVID-19 Vaccine - Manufacturer Unknown has been requested and will be submitted if and when received.
Patient described pain, swelling, and redness at injection sites starting the evening of 10/30/2020. The pain limited her range of motion and caused issues at work Friday night. She also began experiencing chills and fever late night 10/30/2020. The chills and fever have slightly subsided as of 10/31/2020 but the pain, swelling, and redness remains.  She has used ibuprofen every 4 hours to treat the symptoms.
First dose administered 1/29/21 and second dose was administered on 2/9/21. No adverse reaction reported by patient.
mom brought pt in afternoon of 26JUL96 w/large (approx 5in diameter) area of redness & discoloration;area was warm-red w/blanching in central area;seen by MD -dx allergic rxn to tetanus; 8JUL96 bulbous lesion of skin
Patient presented to the ED on 10/9/2021 complaining of a three day history of abdominal discomfort/cramping, abdominal distension and nausea. CT scan of the abdomen and pelvis revealed a partial small bowel obstruction with transition point in the RLQ. She was admitted to the Acute Care Surgery Service for bowel rest and IV fluids - symptoms resolved and she began having bowel movements. Discharged to home. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Adverse events included: tingling in numbness in right arm and hand. Rush of heat throughout upper body. Significant headache. Blood pressure increased to approximately 160/80  (normal for me is ~138/80). Face went beet red, per clinical observations.  Treatment: Benadryl and continued observation for total of 1.5 hours.  Following above, I returned home and slept for approximate 6 hours and rested remainder of day.  Felt fine/back to normal within 24 hours.
Drug ineffective; Suspected COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown). The reporter is the patient.  An adult female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; SUSPECTED COVID-19 (medically significant), outcome "unknown". Clinical course: Patient got fully vaccinated then she got boosted twice and she still wound up got covid-19 twice so as of this moment she do not saw the point and got another booster, all honesty was God almighty means for her to get sick with covid again she was going to get sick with covid again whether or not she had boosted herself with getting one of the shots from her doctor.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient experience acute altered mental status on Friday 5/21; seen in ER on Sat 5/22 and Mon 5/24
The day after her shot, the patient had diarrhea, and inconsolable crying. The 2nd day after her shot, the patient slept most of day. The 3rd day after the shots, the patient had a rash on the front if his torso, hives on the buttocks and post lateral thigh. Bath and take Benadryl.
Patient with left side MEN-B (BEXSERO) (Meningococcal B) OMV given, right side MEN-ACYW (MENVEO) (meningococcal oligosaccharide ACYW-135).  1 month ago, Men-B (Bexsero given with neck pain).  Severe pain on injection radiating with numb/tingling on right side immediately.  Then severe fatigue, slowness in thought and movement, at least 3 days, still having symptoms - could not work.
Fevers 101.8, body aches, chills.  Fevers respond to acetaminophen but recur within hours.  This is the 3rd day of symptoms
chronic fatigue & joint pain;23APR98 redness @ inj site;28APR98 low grade fever, rash, lymphadenopathy;4MAY no rash;fatigue, lethargy, joint pain;7JUL ongoing profound fatigue;
CHILD WENT INTO ANAPHYLAXIS ~ 20 MINUTES POST H1N1 LAIV VAX. EPINEPHRINE (0.4 ML) ADMINISTERED. 9-1-1 CALLED. EMS ADMINISTERED OXYGEN AND TRANSPORTED CHILD TO E.R. CHILD GIVEN 2 ALBUTEROL TREATMENTS AND IS IN STABLE CONDITION. ADMITTED TO HOSPITAL FOR OBSERVATION/TESTING.  11/20/09 Medical records receoved for DOS 11/19/09. Final DX: Allergic reaction acute.  5 min S/P nasal mist vaccine c/o SOB, heart racing, sore throat, wheezes bil. steroid and neb tx. D/C to home.
MOTHER REPORTS WARMTH, REDNESS AND SWELLING TO SITE. PARENT ADVISED TO APPLY COLD COMPRESS/ICE TO SITE. ADMINISTER ACETAMINOPHEN OR IBUPROFEN, IF DESIRED.